-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC THERAPEUTICS ANNOUNCES HEALTH CANADA APPROVAL OF SEPHIENCE™ (SEPIAPTERIN) FOR THE TREATMENT OF CHILDREN AND ADULTS LIVING WITH PHENYLKETONURIA (PKU)

Reuters·12/10/2025 13:00:01

Please log in to view news